chrX-12716641-G-A
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_001368397.1(FRMPD4):c.2182G>A(p.Ala728Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000196 in 1,207,976 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 77 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001368397.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FRMPD4 | NM_001368397.1 | c.2182G>A | p.Ala728Thr | missense_variant | 15/17 | ENST00000675598.1 | NP_001355326.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FRMPD4 | ENST00000675598.1 | c.2182G>A | p.Ala728Thr | missense_variant | 15/17 | NM_001368397.1 | ENSP00000502607.1 |
Frequencies
GnomAD3 genomes AF: 0.0000896 AC: 10AN: 111659Hom.: 0 Cov.: 22 AF XY: 0.000118 AC XY: 4AN XY: 33829
GnomAD3 exomes AF: 0.0000927 AC: 17AN: 183415Hom.: 0 AF XY: 0.0000590 AC XY: 4AN XY: 67847
GnomAD4 exome AF: 0.000207 AC: 227AN: 1096317Hom.: 0 Cov.: 32 AF XY: 0.000202 AC XY: 73AN XY: 361705
GnomAD4 genome AF: 0.0000896 AC: 10AN: 111659Hom.: 0 Cov.: 22 AF XY: 0.000118 AC XY: 4AN XY: 33829
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Mar 04, 2015 | - - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 28, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at